$166.99
0.89% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US23918K1088
Symbol
DVA

DaVita HealthCare Partners Stock price

$166.99
+10.00 6.37% 1M
+28.45 20.54% 6M
+62.23 59.40% YTD
+67.60 68.01% 1Y
+64.99 63.72% 3Y
+93.60 127.54% 5Y
+91.93 122.48% 10Y
NYSE, Closing price Mon, Nov 25 2024
+1.48 0.89%
ISIN
US23918K1088
Symbol
DVA
Sector

Key metrics

Market capitalization $13.69b
Enterprise Value $26.54b
P/E (TTM) P/E ratio 18.00
EV/FCF (TTM) EV/FCF 18.64
EV/Sales (TTM) EV/Sales 2.10
P/S ratio (TTM) P/S ratio 1.08
P/B ratio (TTM) P/B ratio 35.68
Revenue growth (TTM) Revenue growth 6.34%
Revenue (TTM) Revenue $12.67b
EBIT (operating result TTM) EBIT $1.88b
Free Cash Flow (TTM) Free Cash Flow $1.42b
Cash position $1.18b
EPS (TTM) EPS $9.28
P/E forward 16.97
P/S forward 1.07
EV/Sales forward 2.08
Short interest 9.58%
Show more

Is DaVita HealthCare Partners a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

DaVita HealthCare Partners Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a DaVita HealthCare Partners forecast:

2x Buy
18%
7x Hold
64%
2x Sell
18%

Analyst Opinions

11 Analysts have issued a DaVita HealthCare Partners forecast:

Buy
18%
Hold
64%
Sell
18%

Financial data from DaVita HealthCare Partners

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
12,667 12,667
6% 6%
100%
- Direct Costs 9,257 9,257
3% 3%
73%
3,410 3,410
18% 18%
27%
- Selling and Administrative Expenses 780 780
10% 10%
6%
- Research and Development Expense - -
-
-
2,630 2,630
20% 20%
21%
- Depreciation and Amortization 745 745
0% 0%
6%
EBIT (Operating Income) EBIT 1,885 1,885
30% 30%
15%
Net Profit 828 828
39% 39%
7%

In millions USD.

Don't miss a Thing! We will send you all news about DaVita HealthCare Partners directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DaVita HealthCare Partners Stock News

Positive
The Motley Fool
about 24 hours ago
Warren Buffett, the longtime head of Berkshire Hathaway (BRK.A 0.99%) (BRK.B 0.95%), has delivered an impressive nearly 20% annualized return for shareholders since 1965, doubling the S&P 500's benchmark return. These exceptional results stem from Buffett and his late partner Charlie Munger's business acumen, combined with Berkshire's ability to strategically invest funds generated by its insur...
Positive
Investors Business Daily
12 days ago
Buying a stock is easy, but buying the right stock without a good strategy is incredibly hard. Here are five top-performing stocks to buy now or put on a watchlist.
Negative
Seeking Alpha
12 days ago
Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces significant risks from debt servicing costs, macroeconomic factors, and potential policy changes. The company's recent financial performance, including a decline in net income and increased debt costs, under...
More DaVita HealthCare Partners News

Company Profile

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Head office United States
CEO Javier Rodriguez
Employees 70,000
Founded 1994
Website www.davita.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today